Name: UMIN ID:
Unique ID issued by UMIN | UMIN000027432 |
---|---|
Receipt number | R000031396 |
Scientific Title | Afatinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring active EGFR mutations : an open-label, randomized, multicenter, phase II study |
Date of disclosure of the study information | 2017/06/18 |
Last modified on | 2019/06/06 11:49:03 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/05/21 23:35:24 | ||
2 | Update | 2017/09/15 18:12:35 | Recruitment status |
|
3 | Update | 2019/06/06 11:49:03 | Recruitment status Date of IRB Last follow-up date Other related information |